Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research.

Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research.

Patients who develop an active tuberculosis infection during tumor necrosis factor (TNF) inhibitor treatment typically discontinue TNF inhibitor and receive standard anti-tuberculosis treatment. However, there is currently insufficient information on patient outcomes following resumption of TNF inhi...

Full description

Bibliographic Details
Main Authors: Hye Won Kim, Seong Ryul Kwon, Kyong-Hee Jung, Seong-Kyu Kim, Han Joo Baek, Mi Ryung Seo, So-Young Bang, Hye-Soon Lee, Chang-Hee Suh, Ju Yang Jung, Chang-Nam Son, Seung Cheol Shim, Sang-Hoon Lee, Seung-Geun Lee, Yeon-Ah Lee, Eun Young Lee, Tae-Hwan Kim, Yong-Gil Kim, Korean Society of Spondyloarthritis Research
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4839632?pdf=render

Internet

http://europepmc.org/articles/PMC4839632?pdf=render

Similar Items